Poly‐GP in cerebrospinal fluid links C9orf72‐associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The C9orf72 GGGGCC repeat expansion is a major cause of amyotrophic lateral sclerosis and frontotemporal dementia (c9ALS/FTD).Non-conventional repeat translation results in five dipeptide repeat proteins (DPRs), but their clinical utility, overall significance, and temporal course in the pathogenesis of c9ALS/FTD are unclear, although animal models support a gain-of-function mechanism.Here, we established a poly-GP immunoassay from cerebrospinal fluid (CSF) to identify and characterize C9orf72 patients.Significant poly-GP levels were already detectable in asymptomatic C9orf72 mutation carriers compared to healthy controls and patients with other neurodegenerative diseases.The poly-GP levels in asymptomatic carriers were similar to symptomatic c9ALS/FTD cases.Poly-GP levels were not correlated with disease onset, clinical scores, and CSF levels of neurofilaments as a marker for axonal damage.Poly-GP determination in CSF revealed a C9orf72 mutation carrier in our cohort and may thus be used as a diagnostic marker in addition to genetic testing to screen patients.Presymptomatic expression of poly-GP and likely other DPR species may contribute to disease onset and thus represents an alluring therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In C9orf72 expansion carriers, poly(GP), one of the DPR proteins produced by the C9orf72 expansions, is elevated as early as the presymptomatic phase.”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [109]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 1×
“Formation of repeat RNA foci in the nucleus and the accompanying sequestration of RNA-binding proteins are thought to alter RNA processing (DeJesus-Hernandez et al, 2011).”
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811 · cited 1×
“Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative diseases with similar neuropathological features and overlapping clinical symptoms and pathomechanisms (Ling et al, 2013).”
State of play in amyotrophic lateral sclerosis genetics
Renton, A. E., Chiò, A., & Traynor, B. J. (2014) · Nature Neuroscience · doi:10.1038/nn.3584 · Cited by 1,544
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S.-M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Van Broeckhoven, C., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,277
Self-citationAsh, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T., Lin, W.-L., DeJesus-Hernandez, M., van Blitterswijk, M. M., Jansen-West, K., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,100
Non-ATG–initiated translation directed by microsatellite expansions
Zu, T., Gibbens, B., Doty, N. S., Gomes-Pereira, M., Huguet, A., Stone, M. D., Margolis, J., Peterson, M., Markowski, T. W., Ingram, M. A. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013343108 · Cited by 903
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia
Zu, T., Liu, Y., Bañez-Coronel, M., Reid, T., Pletnikova, O., Lewis, J., Miller, T. M., Harms, M. B., Falchook, A. E., Subramony, S. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315438110 · Cited by 760
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins
Mizielinska, S., Grönke, S., Niccoli, T., Ridler, C. E., Clayton, E. L., Devoy, A., Moens, T., Norona, F. E., Woollacott, I. O. C., Pietrzyk, J., et al. (2014) · Science · doi:10.1126/science.1256800 · Cited by 740 · cited 2×
“Since poly-GR/PR and poly-GA are by far more toxic than polyGP in cellular and animal models (Mizielinska et al, 2014), it will be critical to determine their levels during disease progression to better address the role of DPRs in c9ALS/FTD pathogenesis.”
Jovičić, A., Mertens, J., Boeynaems, S., Bogaert, E., Chai, N., Yamada, S. B., Paul, J. W., Sun, S., Herdy, J. R., Bieri, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4085 · Cited by 598
Gendron, T. F., Bieniek, K. F., Zhang, Y.-J., Jansen-West, K., Ash, P. E. A., Caulfield, T., Daughrity, L., Dunmore, J. H., Castanedes-Casey, M., Chew, J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1192-8 · Cited by 581
Cited by
Neurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988
Self-citationC9orf72-mediated ALS and FTD: multiple pathways to disease
Balendra, R., & Isaacs, A. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0047-2 · Cited by 715
An update on genetic frontotemporal dementia
Greaves, C. V., & Rohrer, J. D. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09363-4 · Cited by 500
(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-63233-3.00009-9 · Cited by 421
RNA-binding proteins in neurodegeneration: mechanisms in aggregate
Conlon, E. G., & Manley, J. L. (2017) · Genes & Development · doi:10.1101/gad.304055.117 · Cited by 231
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
Heller, C., Foiani, M. S., Moore, K., Convery, R., Bocchetta, M., Neason, M., Cash, D. M., Thomas, D., Greaves, C. V., Woollacott, I. O., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321954 · Cited by 182
Self-citationFrontotemporal lobar degeneration
Grossman, M., Seeley, W. W., Boxer, A. L., Hillis, A. E., Knopman, D. S., Ljubenov, P. A., Miller, B., Piguet, O., Rademakers, R., Whitwell, J. L., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00447-0 · Cited by 178
Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis
Volk, A. E., Weishaupt, J. H., Andersen, P. M., Ludolph, A. C., & Kubisch, C. (2018) · Medizinische Genetik · doi:10.1007/s11825-018-0185-3 · Cited by 156
Self-citationOeckl, P., Weydt, P., Steinacker, P., Anderl-Straub, S., Nordin, F., Volk, A. E., Diehl-Schmid, J., Andersen, P. M., Kornhuber, J., Danek, A., et al. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318868 · Cited by 139
Self-citationBiomarkers in Motor Neuron Disease: A State of the Art Review
Verber, N. S., Shepheard, S. R., Sassani, M., McDonough, H. E., Moore, S. A., Alix, J. J. P., Wilkinson, I. D., Jenkins, T. M., & Shaw, P. J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00291 · Cited by 130
Fluid biomarkers in frontotemporal dementia: past, present and future
Swift, I. J., Sogorb-Esteve, A., Heller, C., Synofzik, M., Otto, M., Graff, C., Galimberti, D., Todd, E., Heslegrave, A. J., van der Ende, E. L., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323520 · Cited by 122
Self-citationKoníčková, D., Menšíková, K., Tučková, L., Hényková, E., Strnad, M., Friedecký, D., Stejskal, D., Matěj, R., & Kaňovský, P. (2022) · Biomedicines · doi:10.3390/biomedicines10071760 · Cited by 118
Fluid biomarkers for amyotrophic lateral sclerosis: a review
Irwin, K. E., Sheth, U., Wong, P. C., & Gendron, T. F. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00685-6 · Cited by 104
Fenoglio, C., Scarpini, E. A., Serpente, M., & Galimberti, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170702 · Cited by 101
Denk, J., Oberhauser, F., Kornhuber, J., Wiltfang, J., Fassbender, K., Schroeter, M. L., Volk, A. E., Diehl-Schmid, J., Prudlo, J., Danek, A., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0197329 · Cited by 89
Self-citationBiomarker-guided decision making in clinical drug development for neurodegenerative disorders
Cummings, J. L., Teunissen, C. E., Fiske, B. K., Ber, I. L., Wildsmith, K. R., Schöll, M., Dunn, B., & Scheltens, P. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01165-w · Cited by 89
Repeat-Associated Non-ATG Translation: Molecular Mechanisms and Contribution to Neurological Disease
Nguyen, L., Cleary, J. D., & Ranum, L. P. W. (2019) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070918-050405 · Cited by 85
Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion
Leko, M. B., Župunski, V., Kirincich, J., Smilović, D., Hortobágyi, T., Hof, P. R., & Šimić, G. (2019) · Behavioural Neurology · doi:10.1155/2019/2909168 · Cited by 84
Preclinical progression of neurodegenerative diseases.
Katsuno, M., Sahashi, K., Iguchi, Y., & Hashizume, A. (2018) · PubMed · doi:10.18999/nagjms.80.3.289 · Cited by 83
C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies
Vatsavayai, S. C., Nana, A. L., Yokoyama, J. S., & Seeley, W. W. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1921-0 · Cited by 83
Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD
Schmitz, A., Marques, J. P., Oertig, I., Maharjan, N., & Saxena, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.637548 · Cited by 76
Younes, K., & Miller, B. L. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.02.006 · Cited by 72
Transcriptome alterations in myotonic dystrophy frontal cortex
Otero, B. A., Poukalov, K., Hildebrandt, R. P., Thornton, C. A., Jinnai, K., Fujimura, H., Kimura, T., Hagerman, K. A., Sampson, J. B., Day, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108634 · Cited by 72
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia
Benussi, A., Alberici, A., Samra, K., Russell, L. L., Greaves, C. V., Bocchetta, M., Ducharme, S., Finger, E. C., Fumagalli, G., Galimberti, D., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12485 · Cited by 67
From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis
Morello, G., Salomone, S., D’Agata, V., Conforti, F. L., & Cavallaro, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.577755 · Cited by 65
Active poly‐GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model
Zhou, Q., Mareljic, N., Michaelsen, M., Parhizkar, S., Heindl, S., Nuscher, B., Farny, D., Czuppa, M., Schludi, C., Graf, A., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910919 · Cited by 64
Self-citationPoly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers
Meeter, L. H. H., Gendron, T. F., Sias, A. C., Jiskoot, L. C., Russo, S. P., Donker Kaat, L., Papma, J. M., Panman, J. L., van der Ende, E. L., Dopper, E. G., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.559 · Cited by 61
Mizielinska, S., Hautbergue, G. M., Gendron, T. F., van Blitterswijk, M., Hardiman, O. M., Ravits, J., Isaacs, A. M., & Rademakers, R. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00026-2 · Cited by 59
Abugable, A. A., Morris, J. L. M., Palminha, N. M., Zaksauskaite, R., Ray, S., & El‐Khamisy, S. F. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102669 · Cited by 58
Biomarkers for diseases with TDP-43 pathology
Steinacker, P., Barschke, P., & Otto, M. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.10.003 · Cited by 57
Self-citationThe presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?
Chipika, R. H., Siah, W. F., McKenna, M. C., Shing, S. L. H., Hardiman, O. M., & Bede, P. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10289-5 · Cited by 57
Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD
Krishnan, G., Raitcheva, D., Bartlett, D. A., Prudencio, M., McKenna-Yasek, D. M., Douthwright, C. L., Oskarsson, B., Ladha, S. S., King, O. D., Barmada, S. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30387-4 · Cited by 57
TDP-43 Proteinopathy Specific Biomarker Development
Cordts, I., Wachinger, A., Scialò, C., Lingor, P., Polymenidou, M., Buratti, E., & Feneberg, E. (2023) · Cells · doi:10.3390/cells12040597 · Cited by 55
Self-citationdel Campo, M., Zetterberg, H., Gandy, S., Onyike, C. U., Oliveira, F., Udeh‐Momoh, C., Lleó, A., Teunissen, C. E., & Pijnenburg, Y. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12643 · Cited by 52
Todd, T. W., McEachin, Z. T., Chew, J., Burch, A. R., Jansen‐West, K. R., Tong, J., Yue, M., Song, Y., Castanedes‐Casey, M., Kurti, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107616 · Cited by 52
Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers
Cammack, A. J., Atassi, N., Hyman, T. S., van den Berg, L. H., Harms, M. B., Baloh, R. H., Brown, R. H., van Es, M. A., Veldink, J. H., de Vries, B. S., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008359 · Cited by 50
Liu, F., Morderer, D., Wren, M. C., Vettleson-Trutza, S. A., Wang, Y., Rabichow, B. E., Salemi, M., Phinney, B. S., Oskarsson, B., Dickson, D. W., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01322-x · Cited by 50
Review: Fluid biomarkers for frontotemporal dementias
Zetterberg, H., van Swieten, J. C., Boxer, A. L., & Rohrer, J. D. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12530 · Cited by 48
Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
Katzeff, J. S., Bright, F., Phan, K., Kril, J. J., Ittner, L. M., Kassiou, M., Hodges, J. R., Piguet, O., Kiernan, M. C., Halliday, G. M., et al. (2022) · Brain · doi:10.1093/brain/awac077 · Cited by 48
Amyotrophic lateral sclerosis: the complex path to precision medicine
Talbot, K., Feneberg, E., Scaber, J., Thompson, A. G., & Turner, M. R. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8983-8 · Cited by 47
Self-citationBiomarkers for amyotrophic lateral sclerosis
Witzel, S., Mayer, K., & Oeckl, P. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001094 · Cited by 46
Self-citationJiang, J., & Ravits, J. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00797-2 · Cited by 44
Younger, D. S., & Brown, R. H. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00031-4 · Cited by 40
Neurochemical biomarkers in amyotrophic lateral sclerosis
Verde, F., Silani, V., & Otto, M. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000744 · Cited by 40
Self-citationFloeter, M. K., & Gendron, T. F. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01063 · Cited by 40
Mitropoulos, K. A., Κάτσιλα, Θ., Patrinos, G. P., & Pampalakis, G. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0183 · Cited by 39
Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis
Ito, D., Hashizume, A., Hijikata, Y., Yamada, S., Iguchi, Y., Iida, M., Kishimoto, Y., Moriyoshi, H., Hirakawa, A., & Katsuno, M. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09507-6 · Cited by 39
Sattler, R., Traynor, B. J., Robertson, J., Bosch, L. V. D., Barmada, S. J., Svendsen, C. N., Disney, M. D., Gendron, T. F., Wong, P. C., Turner, M. R., et al. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00548-8 · Cited by 34
Updates on Disease Mechanisms and Therapeutics for Amyotrophic Lateral Sclerosis
Nguyen, L. (2024) · Cells · doi:10.3390/cells13110888 · Cited by 34
Circulating Biomarkers in Neuromuscular Disorders: What Is Known, What Is New
Barp, A., Ferrero, A., Casagrande, S., Morini, R., & Zuccarino, R. (2021) · Biomolecules · doi:10.3390/biom11081246 · Cited by 33
Wilson, K. M., Katona, E., Glaria, I., Carcolé, M., Swift, I. J., Sogorb‐Esteve, A., Heller, C., Bouzigues, A., Heslegrave, A., Keshavan, A., et al. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-328710 · Cited by 32
Self-citationRecent advances in understanding frontotemporal degeneration
Borroni, B., & Benussi, A. (2019) · F1000Research · doi:10.12688/f1000research.20330.1 · Cited by 32
Fujino, Y., Ueyama, M., Ishiguro, T., Ozawa, D., Ito, H., Sugiki, T., Murata, A., Ishiguro, A., Gendron, T. F., Mori, K., et al. (2023) · eLife · doi:10.7554/elife.84338 · Cited by 32
Genetic Diversity in Frontotemporal Dementia
Shpilyukova, Y. A., Fedotova, E. Y., & Illarioshkin, S. N. (2020) · Molecular Biology · doi:10.1134/s0026893320010136 · Cited by 32
Czuppa, M., Dhingra, A., Zhou, Q., Schludi, C., König, L. E., Scharf, E., Farny, D., Dalmia, A., Täger, J., Castillo-Lizardo, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110913 · Cited by 29
Self-citationA Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach
Alshehri, R. S., Abuzinadah, A. R., Alrawaili, M. S., Alotaibi, M. K., Alsufyani, H. A., Alshanketi, R. M., & Alshareef, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010900 · Cited by 26
Frontotemporal dementia. How to deal with its diagnostic complexity?
Antonioni, A., Raho, E. M., Granieri, E., & Koch, G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2461758 · Cited by 25
A Report From the 8th Kuopio Alzheimer Symposium
Haapasalo, A., & Hiltunen, M. (2018) · Neurodegenerative Disease Management · doi:10.2217/nmt-2018-0029 · Cited by 25
de Calbiac, H., Renault, S., Haouy, G., Jung, V. A., Roger, K., Zhou, Q., Campanari, M., Chentout, L., Demy, D. L., Marian, A., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2358736 · Cited by 24
Self-citationMori, K., Gotoh, S., Yamashita, T., Uozumi, R., Kawabe, Y., Tagami, S., Kamp, F., Nuscher, B., Edbauer, D., Haass, C., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101120 · Cited by 24
Self-citationQuerin, G., Biferi, M. G., & Pradat, P. (2021) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-210754 · Cited by 24
Goodman, L. D., & Bonini, N. M. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101697 · Cited by 23
Prodromal and Early bvFTD: Evaluating Clinical Features and Current Biomarkers
Katisko, K., Cajanus, A., Korhonen, T., Remes, A. M., Haapasalo, A., & Solje, E. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00658 · Cited by 22
Zhang, F., Rakhimbekova, A., Lashley, T., & Madl, T. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102400 · Cited by 20
Reyes‐Leiva, D., Dols‐Icardo, O., Sirisi, S., Cortés‐Vicente, E., Turón‐Sans, J., de Luna, N., Blesa, R., Belbin, O., Montal, V., Alcolea, D. A., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.750543 · Cited by 19
Repeated mild traumatic brain injury triggers pathology in asymptomatic C9ORF72 transgenic mice
Kahriman, A., Bouley, J., Tuncali, I., Dogan, E. O., Pereira, M., Luu, T., Bosco, D. A., Jaber, S., Peters, O. M., Brown, R. H., et al. (2023) · Brain · doi:10.1093/brain/awad264 · Cited by 18
Nuytemans, K., Franzen, S., Broce, I., Caramelli, P., Ellajosyula, R., Finger, E. C., Gupta, V. B., Gupta, V., Illán‐Gala, I., Loi, S. M., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14312 · Cited by 17
Gill, A. L., Wang, M. Z., Levine, B. A., Premasiri, A. S., & Vieira, F. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246238 · Cited by 17
Adil, O., Adeyeye, C., & Shamsi, M. H. (2024) · ACS Sensors · doi:10.1021/acssensors.4c01150 · Cited by 17
Sánchez‐Tejerina, D., Llauradó, A., Sotoca, J., López‐Diego, V., Vidal-Taboada, J. M., Salvadó, M., & Morales, R. J. (2023) · Cells · doi:10.3390/cells12081180 · Cited by 16
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Rogers, M., Schultz, D. W., Karnaros, V., & Shepheard, S. R. (2023) · Brain Communications · doi:10.1093/braincomms/fcad287 · Cited by 15
Sonobe, Y., Lee, S., Krishnan, G., Gu, Y., Kwon, D. Y., Gao, F., Roos, R. P., & Kratsios, P. (2023) · eLife · doi:10.7554/elife.83189 · Cited by 15
Moinuddin, O., Khandwala, N. S., Young, K. Z., Sathrasala, S. K., Barmada, S. J., Albin, R. L., & Besirli, C. G. (2021) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001041 · Cited by 15
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies
Balendra, R., Moens, T. G., & Isaacs, A. M. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707848 · Cited by 13
Sultana, J., Ragagnin, A., Parakh, S., Saravanabavan, S., Soo, K. Y., Vidal, M., Jagaraj, C. J., Ding, K., Wu, S., Shadfar, S., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04187-4 · Cited by 13
Генетическое разнообразие лобно-височной деменции
Шпилюкова, Ю. А., Fedotova, E. Y., & Illarioshkin, S. N. (2020) · Molecular Biology · doi:10.31857/s0026898420010139 · Cited by 13
Fluid Biomarkers of Frontotemporal Lobar Degeneration
van der Ende, E. L., & Swieten, J. C. V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_9 · Cited by 12
Aberrant protein aggregation in amyotrophic lateral sclerosis
Wang, H., & Zeng, R. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12485-z · Cited by 12
Gagliardi, D., Costamagna, G., Taiana, M. M., Andreoli, L., Biella, F., Bersani, M., Bresolin, N., Comi, G. P., & Corti, S. P. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101172 · Cited by 12
Verde, F., Licaj, S., Soranna, D., Ticozzi, N., Silani, V., & Zambon, A. (2024) · European Journal of Neurology · doi:10.1111/ene.16371 · Cited by 11
Zubizarreta, I. K., Manero-Azua, Á., Afonso-Agüera, J., & de Nanclares, G. P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091396 · Cited by 9
Neurochemical biomarkers of amyotrophic lateral sclerosis: recent developments
Verde, F. (2025) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001411 · Cited by 9
Tzeplaeff, L., Galhoz, A., Meijs, C., Gomes, L. C., Kováč, A., Menzel, A., Değirmenci, H., Alaamel, A., Kaya, H. C., Çelik, A. G., et al. (2025) · Neurological Research and Practice · doi:10.1186/s42466-025-00417-9 · Cited by 8
Scarcella, S., Brambilla, L., Quetti, L., Rizzuti, M., Melzi, V., Galli, N., Sali, L., Costamagna, G., Comi, G. P., Corti, S., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf114 · Cited by 8
Nevler, N., Cho, S., Cousins, K. A. Q., Ash, S., Olm, C. A., Shellikeri, S., Agmon, G., Gonzalez-Recober, C., Xie, S. X., Barker, M. S., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000207926 · Cited by 7
Preclinical and Prodromal Frontotemporal Dementia: Challenges and Opportunities
Palacino, F., Manganotti, P., & Benussi, A. (2025) · International Journal of Translational Medicine · doi:10.3390/ijtm5040052 · Cited by 7
Saracino, D., & Ber, I. L. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.03.007 · Cited by 7
Dellar, E. R., Vendrell, I., Amein, B., Lester, D., Edmond, E., Yoganathan, K. T., Dharmadasa, T., Sogorb‐Esteve, A., Fischer, R., Talbot, K., et al. (2024) · Annals of Neurology · doi:10.1002/ana.27133 · Cited by 7
Design considerations for C9orf72 disease prevention trials
Benatar, M. G., Staffaroni, A. M., Wuu, J., McDermott, M. P., Quintana, M., Swidler, J., Andersen, G., Huey, E. D., Turner, M. R., Macklin, E. A., et al. (2025) · Brain · doi:10.1093/brain/awaf290 · Cited by 6
A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis
Pampalakis, G., Angelis, G., Zingkou, E., Vekrellis, K., & Sotiropoulou, G. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.657 · Cited by 6
Mori, K., Gotoh, S., Uozumi, R., Miyamoto, T., Akamine, S., Kawabe, Y., Tagami, S., & Ikeda, M. (2023) · JMA Journal · doi:10.31662/jmaj.2022-0160 · Cited by 6
Current neuroprotective therapies and future prospects for motor neuron disease
Evans, L. J., O’Brien, D., & Shaw, P. J. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.003 · Cited by 5
Fluid biomarkers in familial frontotemporal dementia: progress and prospects
Guo, M., Qin, L., Cai, H., Wang, R., Luo, C., Yang, F., Feng, S., Gao, H., & Chen, Q. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1663609 · Cited by 4
Basic Concepts and Emergent Disease Mechanisms of Amyotrophic Lateral Sclerosis
Sirozh, O., Sáez-Mas, A., Lafarga, V., & Fernández-Capetillo, Ó. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00266-2 · Cited by 4
Synofzik, M., Otto, M., Ludolph, A., & Weishaupt, J. H. (2017) · Der Nervenarzt · doi:10.1007/s00115-017-0349-4 · Cited by 4
Self-citationMultimodal strategies for diagnosis, stratification, and therapeutic monitoring in ALS
López‐Blanch, R., Oriol‐Caballo, M., Estrela, J. M., & Obrador, E. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106727 · Cited by 3
Roy, A. R. K., Noohi, F., Morris, N., Ljubenkov, P. A., Heuer, H. W., Fong, J. C., Hall, M., Lago, A. L., Rankin, K. P., Miller, B. L., et al. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103649 · Cited by 3
Ryan, B., Baker, A. O., Ilse, C., Brickell, K. L., Kersten, H. M., Williams, J. M., Addis, D. R., Tippett, L. J., & Curtis, M. A. (2022) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2022.2101483 · Cited by 3
Fourier, A., Formaglio, M., Sauvée, M., Perret‐Liaudet, A., Latour, P., Bost, M., & Quadrio, I. (2018) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000492963 · Cited by 2
Miyagi, T., & Kanekura, K. (2023) · Organelle · doi:10.61747/0ifp.202311001 · Cited by 2
Metadata
- Authors
- Lehmer, C., Oeckl, P., Weishaupt, J. H., Volk, A. E., Diehl‐Schmid, J., Schroeter, M. L., Lauer, M., Kornhuber, J., Levin, J., Fassbender, K., Landwehrmeyer, B., German Consortium for Frontotemporal Lobar Degeneration, Schludi, M. H., Arzberger, T., Kremmer, E., Flatley, A., Feederle, R., Steinacker, P., Weydt, P., Ludolph, A. C., Edbauer, D., Otto, M., Danek, A., Feneberg, E., Anderl‐Straub, S., von Arnim, C., Jahn, H., Schneider, A., Maler, M., Polyakova, M., Riedl, L., Wiltfang, J., & Ziegler, G.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- University Hospital Ulm (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Technical University of Munich (DE)
- University Hospital Leipzig (DE)
- Universitätsklinikum Würzburg (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Saarland University (DE)
- Helmholtz Munich (DE)
- University Hospital Bonn (DE)
- Corresponding author
- Edbauer, Dieter
- Otto, Markus
- ORCID
- Oeckl, Patrick
- Weishaupt, Jochen H
- Volk, Alexander E
- Diehl‐Schmid, Janine
- Schroeter, Matthias L
- Lauer, Martin
- Kornhuber, Johannes
- Levin, Johannes
- Fassbender, Klaus
- Kremmer, Elisabeth
- Flatley, Andrew
- Feederle, Regina
- Steinacker, Petra
- Weydt, Patrick
- Ludolph, Albert C
- Edbauer, Dieter
- Otto, Markus
- Danek, Adrian
- Feneberg, Emily
- Jahn, Holger
- Schneider, Anja
- Wiltfang, Jens
- Ziegler, Georg
- Venue
- EMBO Molecular Medicine
- Published
- 2017-04-13
- Volume
- 9
- Issue
- 7
- Pages
- 859-868
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC5494528
- OpenAlex
- W2606980242
- Cited by
- 118
- References
- 41
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 13 · 2023: 17 · 2022: 17 · 2021: 9 · 2020: 11 · 2019: 15 · 2018: 19 · 2017: 4
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- other-oa
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion, cc-by)
- DZNE Pub (submittedVersion, other-oa)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Funders
- JPND Networks SOPHIA (01ED1202A)
- BiomarkAPD (01ED1203F)
- PreFrontAls (01ED1512)
- STRENGTH (01ED1408)
- EU (246513, 633190, 617198)
- German Research Foundation/DFG (VO2028)
- Baden‐Württemberg (D.3830)
- BIU (D.5009)
- Charcot Foundation
- NOMIS Foundation
- Seventh Framework Programme (617198)
- Bundesministerium für Bildung und Forschung (O1GI1007A, 01GM1103A)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- C9orf72, GGGGCC repeat expansion, dipeptide repeat proteins, cerebrospinal fluid biomarkers, amyotrophic lateral sclerosis, frontotemporal dementia, presymptomatic carriers, gain-of-function mechanism, disease onset, neurofilaments, immunoassay
- MeSH terms
- C9orf72 Protein, Amyotrophic Lateral Sclerosis, Cerebrospinal Fluid, Cross-Sectional Studies, Dipeptides, Humans, Immunoassay, Peptides, Biomarkers, Gene Expression, Repetitive Sequences, Amino Acid, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.